Vnitr Lek 2007, 53(5):486-488

Diabetes mellitus and cognitive impairments

I. Tůma
Psychiatrická klinika Lékařské fakulty UK a FN Hradec Králové, přednosta prof. MUDr. Jan Libiger, CSc.

Patients with diabetes have an at increased risk of developing cognitive impairment in comparison with the general population. Cognitive dysfunction comprises impairments of executive functions, memory, attention, and psychomotor efficiency. The question of whether recurrent exposure to severe hypoglycaemia promotes long-term cognitive dysfunction is unresolved. The main risk factors for cognitive impairment in diabetes are considered to be chronological age, duration of diabetes, and coexistent microvascular and macrovascular complications. Diabetes should be treated as a risk factor for cognitive impairment. Cognitive dysfunction is associated with poorer ability in diabetes self-care and decreased adherence to antidiabetic treatment.

Keywords: diabetes mellitus; cognition; dementia

Received: January 8, 2007; Published: May 1, 2007  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Tůma I. Diabetes mellitus and cognitive impairments. Vnitr Lek. 2007;53(5):486-488.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Allen KV, Frier BM, Strachan MWJ. The relationship between type 2 diabetes and cognitive dysfunction: longitudinal studies and their methodological limitations. Eur J Pharmacol 2004; 490: 169-175. Go to original source... Go to PubMed...
    2. Brands AMA, Biessels GJ, DeHaan EHF et al. The effects of type 1 diabetes on cognitive performance. Diabetes Care 2005; 28: 726-735. Go to original source... Go to PubMed...
    3. Convit A. Links between cognitive impairment in insulin resistence: an explanatory model. Neurobiol Aging 2005; 26: S31-S35. Go to original source... Go to PubMed...
    4. Debling D, Amelang M, Hasselbach P et al. Diabetes and cognitive function in a population-based study of elderly women and men. J Diabetes and Its Complications 2006; 20: 238-245. Go to original source... Go to PubMed...
    5. Ferguson SC, Blane A, Perros P et al. Cognitive Ability and Brain Structure in Type 1 Diabetes. Diabetes 2003; 52: 149-156. Go to original source... Go to PubMed...
    6. Hendrickx H, McEwen BS, Van der Ouderaa F. Metabolism, mood and cognition in aging: The importance of lifestyle and dietary intervention. Neurobiology of Aging 2005; 26: S1-S5. Go to original source... Go to PubMed...
    7. Kumari M, Marmot M. Diabetes and cognitive function in a middle-aged cohort: findings from the Whitehall II study. Neurology 2005; 65: 1597-1603. Go to original source... Go to PubMed...
    8. Mc Call AL. Altered glycemia and brain-update and potential relevance to the aging brain. Neurobiol Aging 2005; 26(Suppl 1): 70-75. Go to original source... Go to PubMed...
    9. Miles WR, Root HF. Psychologic tests applied to diabetic patients. Arch Int Med 1922; 30: 767-777. Go to original source...
    10. Musen G, Lyoo IK, Sparks CR et al. Effects of type 1 diabetes on gray matter density as measured by voxel-based morphometry. Diabetes 2006; 55: 326-333. Go to original source... Go to PubMed...
    11. Perros P, Deary IJ. Long-term effects of hypoglycaemia on cognitive function and the brain in diabetes. In: Frier BM, Fischer BM (Eds) Hypoglycaemia in Clinical Diabetes. Chichester: Wiley 1999: 187-210.
    12. Stewart R, Liolitsa D. Type 2 diabetes mellitus, cognitive impairment and dementia. Diabet Med 1999; 16: 93-112. Go to original source... Go to PubMed...
    13. Tůma I. Deprese a diabetes. Vnitř Lék 2005; 51(Suppl 2): S94-S98.
    14. Wright CB, Sacco RL, Rundek TR et al. Interleukin-6 associated with cognitive function: the Northern Manhattan Study. J Stroke Cerebrovasc Dis 2006; 15: 34-38. Go to original source... Go to PubMed...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.